CROs and contract manufacturers had a decent second quarter, but they are hoping that big pharma comes through with a burst of trial start-ups in the second half of 2003.
Sep 1, 2003
CROs and CMOs have reported on their second quarter financial performance during July and August. Although revenues and profits were up for most companies reporting, the discussions of market conditions surrounding the financial results had a somewhat unsettled feel. Most contractors expect robust revenues in the second half of 2003 but are clearly nervous about whether the activity will actually materialize.